These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 26248202
1. Differential Effects of Polymer-Surface Decoration on Drug Delivery, Cellular Retention, and Action Mechanisms of Functionalized Mesoporous Silica Nanoparticles. You Y, Hu H, He L, Chen T. Chem Asian J; 2015 Dec; 10(12):2744-54. PubMed ID: 26248202 [Abstract] [Full Text] [Related]
2. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy. Liang C, Wang H, Zhang M, Cheng W, Li Z, Nie J, Liu G, Lian D, Xie Z, Huang L, Zeng X. J Colloid Interface Sci; 2018 Sep 01; 525():1-10. PubMed ID: 29679795 [Abstract] [Full Text] [Related]
3. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy. Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Abnous K, Malaekeh-Nikouei B. Curr Drug Deliv; 2016 Sep 01; 13(7):1176-1182. PubMed ID: 26718488 [Abstract] [Full Text] [Related]
4. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Xue M, Amin M, Shahtahmassebi N, Malaekeh-Nikouei B. Eur J Pharm Biopharm; 2015 Jan 01; 89():248-58. PubMed ID: 25511563 [Abstract] [Full Text] [Related]
5. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Tu J, Wang T, Shi W, Wu G, Tian X, Wang Y, Ge D, Ren L. Biomaterials; 2012 Nov 01; 33(31):7903-14. PubMed ID: 22840227 [Abstract] [Full Text] [Related]
6. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles. Desai D, Prabhakar N, Mamaeva V, Karaman DŞ, Lähdeniemi IA, Sahlgren C, Rosenholm JM, Toivola DM. Int J Nanomedicine; 2016 Nov 01; 11():299-313. PubMed ID: 26855569 [Abstract] [Full Text] [Related]
7. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier. Baghirov H, Karaman D, Viitala T, Duchanoy A, Lou YR, Mamaeva V, Pryazhnikov E, Khiroug L, de Lange Davies C, Sahlgren C, Rosenholm JM. PLoS One; 2016 Nov 01; 11(8):e0160705. PubMed ID: 27547955 [Abstract] [Full Text] [Related]
8. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance. Zhao P, Li L, Zhou S, Qiu L, Qian Z, Liu X, Cao X, Zhang H. Mater Sci Eng C Mater Biol Appl; 2018 Mar 01; 84():108-117. PubMed ID: 29519418 [Abstract] [Full Text] [Related]
9. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells. Niemelä E, Desai D, Nkizinkiko Y, Eriksson JE, Rosenholm JM. Eur J Pharm Biopharm; 2015 Oct 01; 96():11-21. PubMed ID: 26184689 [Abstract] [Full Text] [Related]
11. A robust graft-to strategy to form multifunctional and stealth zwitterionic polymer-coated mesoporous silica nanoparticles. Zhu Y, Sundaram HS, Liu S, Zhang L, Xu X, Yu Q, Xu J, Jiang S. Biomacromolecules; 2014 May 12; 15(5):1845-51. PubMed ID: 24670217 [Abstract] [Full Text] [Related]
13. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery. Zhang Q, Zhao H, Li D, Liu L, Du S. Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088 [Abstract] [Full Text] [Related]
14. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. Xia T, Kovochich M, Liong M, Meng H, Kabehie S, George S, Zink JI, Nel AE. ACS Nano; 2009 Oct 27; 3(10):3273-86. PubMed ID: 19739605 [Abstract] [Full Text] [Related]
15. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy. Ma B, He L, You Y, Mo J, Chen T. Drug Deliv; 2018 Nov 27; 25(1):293-306. PubMed ID: 29334793 [Abstract] [Full Text] [Related]
16. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation. Wang Y, Cui Y, Zhao Y, Zhao Q, He B, Zhang Q, Wang S. J Colloid Interface Sci; 2018 Mar 01; 513():736-747. PubMed ID: 29220688 [Abstract] [Full Text] [Related]
17. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers. Yang K, Luo H, Zeng M, Jiang Y, Li J, Fu X. ACS Appl Mater Interfaces; 2015 Aug 12; 7(31):17399-407. PubMed ID: 26196506 [Abstract] [Full Text] [Related]
18. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells. Xu W, Ge P, Niu B, Zhang X, Liu J, Xie J. J Colloid Interface Sci; 2018 Oct 01; 527():141-150. PubMed ID: 29787950 [Abstract] [Full Text] [Related]
19. Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells. Giménez C, de la Torre C, Gorbe M, Aznar E, Sancenón F, Murguía JR, Martínez-Máñez R, Marcos MD, Amorós P. Langmuir; 2015 Mar 31; 31(12):3753-62. PubMed ID: 25742160 [Abstract] [Full Text] [Related]
20. Mixed shell mesoporous silica nanoparticles for controlled drug encapsulation and delivery. Wu Q, Hou Y, Han G, Liu X, Tang X, Li H, Song X, Zhang G. Nanomedicine (Lond); 2017 Nov 31; 12(22):2699-2711. PubMed ID: 28967827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]